Balaji Amines Limited · NSE:BALAMINES

Balaji Amines — Q1 FY2025 Earnings Presentation

42 slides from Balaji Amines's earnings presentation, Aug 8, 2024

  1. Slide 1: Exchange filing letter for Q1FY25 investor presentation

    8th August, 2024 To, The General Manager-Department of The Manager-Listing Department, Corporate Services, National Stock Exchange of India Limited, BSE Limited, "Exchange Plaza", 5th Floor, Phiroze Jeejeebhoy Towers, Plot No. C/1, G Block, Bandra-Kurla Complex, Dalal Street, Mumbai - 400 001. Bandr

  2. Slide 2: Investor Presentation – August 2024

    Investor Presentation – August 2024

  3. Slide 3: Disclaimer

    Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by Balaji Amines Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securiti

  4. Slide 4: Results Highlights

    Results Highlights About Us Hotel Division Financial Performance Moving towards Growth Prospects

  5. Slide 5: Q1FY25: Financial Highlights

    Q1FY25 : Financial Highlights Revenue (Rs. Crore) EBITDA (Rs. Crore) PAT (Rs. Crore) EBITDA & PAT Margin Consolidated -29% -32% -16% 469 104 106 72 25% 423 68 22% 393 19% 74 17% 46 14% 12% Q1FY24 Q4FY24 Q1FY25 Q1FY24 Q4FY24 Q1FY25 Q1FY24 Q4FY24 Q1FY25 Q1FY24 Q4FY24 Q1FY25 Revenue (Rs. Crore) EBITDA

  6. Slide 6: Q1 FY25 - Consolidated Performance Highlights

    Q1 FY25 - Consolidated Performance Highlights Revenue from Operations for Q1FY25 stood at ₹ 393 crore, as compared to ₹ 423 crore in Q4FY24. Total volumes stood at 28,071 MT for Q1FY25 as against 27,984 MT in Q4FY24. For Q1FY25, • Amines volumes stood at 7,401 MT • Amines Derivatives volumes stood a

  7. Slide 7: Q1FY25 - Consolidated Performance Highlights

    Q1FY25 - Consolidated Performance Highlights • The company is proposing to take up the following projects : o N-Methyl Morpholine (NMM) - 5000 TPA. o N-(n-butyl) Thiophosphoric triamide (NBPT) - 2500 TPA. o Isopropylamine: The company is proposing to manufacture Isopropylamine (Mono & Di) in the exi

  8. Slide 8: Phase-2 & 3 Expansion Plans at our 90-acre Greenfield Project (Unit IV)

    Phase -2 & 3 Expansion Plans at our 90-acre Greenfield Project (Unit IV) EXECUTED ON SCHEDULE IN PROGRESS IN PROGRESS n-Butylamine Methylamines Dimethyl Ether • Market Leader in Methylamines • We have undertaken capex for a new production in India with installed • Dimethyl Ether (DME) with a Capacit

  9. Slide 9: Standalone Statement of Profit & Loss

    Standalone Statement of Profit & Loss Particulars (in Rs. Crore) Q1FY25 Q4FY24 Q-o-Q FY24 FY23 Y-o-Y Total Revenue 338 373 -9% 1,359 1,736 -22% Raw Material 187 190 756 1,005 Employee expense 17 22 72 80 Other expenses 70 66 263 311 EBITDA 64 95 -33% 267 339 -21% EBITDA Margin 19% 25% 20% 20% Deprec

  10. Slide 10: Consolidated Statement of Profit & Loss

    Consolidated Statement of Profit & Loss Particulars (in Rs. Crore) Q1FY25 Q4FY24 Q-o-Q FY24 FY23 Y-o-Y Total Revenue 393 423 -7% 1,671 2,371 -30% Raw Material 217 213 903 1,246 Employee expense 19 25 82 85 Other expenses 82 79 332 415 EBITDA 74 106 -30% 353 624 -43% EBITDA Margin 19% 25% 21% 26% Dep

  11. Slide 11: About Us

    Results Highlights About Us Hotel Division Financial Performance Moving towards Growth Prospects

  12. Slide 12: Amines Industry – Unique but Critical Industry with growth potential

    Amines Industry – Unique but Critical Industry with growth potential The size of Aliphatic Amines industry globally The consumable nature of demand and the is $4.9 billion. Globally, the Amine industry is oligopolistic nature of the industry, results in oligopolistic with two-three producers a stron

  13. Slide 13: Balaji Amines Ltd – A Leading player in Aliphatic Amines in India

    Balaji Amines Ltd – A Leading player in Aliphatic Amines in India State-of-the-art Forward integrated manufacturing suite of products Largest manufacturer of Aliphatic Amines in facilities fully equipped with latest DCS 40+ Product Downstream products added based on strength of amine manufacturing w

  14. Slide 14: Our Products are supplied to India's fast-growing Industries

    Our Products are supplied to India’s fast-growing Industries Industry Wise - Revenue Breakup 3% 4% 3% 4% 3% 2% 4% 51% 26% Pharma Agrochem Paints & Resins Animal Feeds Oil & Gas Rubber Cleaning Chemicals Water Treatment Chemicals Dye and Textiles Others 13

  15. Slide 15: Highly Experienced Management Team

    Highly Experienced Management Team Mr. A. Prathap Reddy Mr. D. Ram Reddy Mr. N. Rajeshwar Reddy Mr. A. Srinivas Reddy Executive Chairman Managing Director Whole Time Director Whole Time Director & CFO • 37 years of experience across • Civil Engineer by Education. various businesses. • B. Com. Over 4

  16. Slide 16: Diversified Product Portfolio

    Diversified Product Portfolio Particulars Amines Amine Derivatives Specialty & Other Chemicals • Aliphatic Amines find increasing • Amine Derivatives are used to make further consumption and applications in a salts and other complex chemical Intermediates and API’s • Albeit a small and fast growing

  17. Slide 17: Clientele

    Clientele Amines Amine Derivatives Specialty & Other Chemicals 16

  18. Slide 18: Well positioned Business Model aimed at Sustainable growth

    Well positioned Business Model aimed at Sustainable growth Focus towards high-value derivatives and Develop new indigenous technology for specialty chemicals with an aim to move up manufacturing products leading to lowering in the value-chain with vertical integration manufacturing costs & improving

  19. Slide 19: Key Products (Current & Proposed) in Portfolio

    Key Products (Current & Proposed) in Portfolio Product Existing Installed Proposed Capacity Project under Application Areas Capacity discussion capacity (TPA) (TPA) (TPA) N-Methyl Morpholine (NMM) 5,000 Pharma , Oil & Gas N-(n-butyl) Thiophosphoric triamide (NBPT) 2,500 Agro Methyl Amine 48,000 40,0

  20. Slide 20: We are Global suppliers – a significant validation of our Capabilities

    We are Global suppliers – a significant validation of our Capabilities • UK • Japan • US • Turkey • Argentina • Finland • Canada • Indonesia • Israel • Switzerland • India • Sri Lanka • Pakistan • Russia • Bangladesh • Malaysia • Oman • Singapore • Germany • Bahrein • Italy • Jordan • Egypt • Guatem

  21. Slide 21: Awards & Certificates – A Testimony of our capabilities

    Awards & Certificates – A Testimony of our capabilities ISO Certificate Two Star Export House ISO Certificate BEST CEO (CHEMICAL INDUSTRY) AWARD TO SHRI ANDE PRATHAP REDDY BY BUSINESS TODAY GROUP 02.05.2023 ISO 9001 : 2015 Certificate Certificate of Merit - CHEMEXCIL First Award - CHEMEXCIL WHO GMP

  22. Slide 22: Awards & Certificates – A Testimony of our capabilities

    Awards & Certificates – A Testimony of our capabilities Product Innovator of the Year Distinguished Contribution in the Excellent CSR in Water Conservation Mahatma Award for Sustainable and in Chemicals – 2018 Indian Chemicals Industry Responsible Business Practice from Aditya Birla Group 1st Octobe

  23. Slide 23: We are Growing…Sustainably and Consistently

    We are Growing…Sustainably and Consistently India Ratings Affirms Balaji Amines’ Bank Facilities at ‘IND AA’ “Latest Rating is Non- fund based Facilities INR 1500 Million IND A1+ ; Fund Based Working Capital Facilities INR 1450 Million IND AA / Stable / IND A1+ • Largest manufacturer of aliphatic am

  24. Slide 24: High entry barrier Business – Paving way for Sustainable growth

    High entry barrier Business – Paving way for Sustainable growth Complex manufacturing process Niche product offering with high High fixed costs, with fixed asset requiring high levels of lead time in customer approvals turns hovering in the range of 1.5- technological know-how. Efficient 2x. Optimum

  25. Slide 25: Well positioned Business Model aimed at Sustainable growth

    Well positioned Business Model aimed at Sustainable growth Value-Added Products Applicability in Solvents segment Capex towards high-value derivatives and specialty chemicals will materialize into higher 01 Solvents account for 80%-90% of the mass utilised in a typical pharmaceutical chemical 05 rev

  26. Slide 26: Greenfield Project to fuel growth and add Revenue Visibility

    Greenfield Project to fuel growth and add Revenue Visibility Strategically Project Accorded Product Profile Balaji Specialty Located Plant Mega Project Status Chemicals Environmental In Phase-1 of Greenfield Electronic Grade DMC Maharashtra’s Energy and clearance received Project Ethylamines Electro

  27. Slide 27: Greenfield Project to fuel growth and add Revenue Visibility

    Greenfield Project to fuel growth and add Revenue Visibility New Products = First High Demand for Hotel Expansion Solar Power Plant Mover advantage Products Significant The demand of Planning to add 40 The 20 MW Greenfield Solar opportunity exists Methylamines has new rooms which Power Plant is prog

  28. Slide 28: Balaji Speciality Chemicals – Production commenced in FY20

    Balaji Speciality Chemicals – Production commenced in FY20 Balaji Speciality Chemicals Limited (BSCL) is Manufacturing products such as Ethylene Diamine 01 (EDA), Piperazine Anhydrous (PIP) , Di Ethylene Tri 04 BAL owns 55% in subsidiary Balaji Speciality Amine (DETA), Amino Ethyl Ethanol Amines (AE

  29. Slide 29: R&D led Investments to provide significant early mover advantage

    R&D led Investments to provide significant early mover advantage New Products Optimization Integration Continuous efforts to optimize Backward and forward Identification of new products utilization of energy, utilities & integration of products to and development of latest raw materials consumption

  30. Slide 30: Hotel Division

    Results Highlights About Us Hotel Division Financial Performance Moving towards Growth Prospects

  31. Slide 31: Balaji Sarovar Premiere – Best in class Business Hotel in Solapur

    Balaji Sarovar Premiere – Best in class Business Hotel in Solapur • Commenced Operations in October 2013 Hotel Balaji Sarovar Premier is the only 5 star hotel in Solapur • Invested Rs. 110 crore in the Hotel Project via mix of Debt and Equity • Tied up with Sarovar Group for the Management of the Ho

  32. Slide 32: Balaji Sarovar Premiere – Q1FY25 Operating Matrix

    Balaji Sarovar Premiere – Q1FY25 Operating Matrix Constitutes 129 Rooms 2.06% of Negligible Routine Capex incurred Rs. 4,835 ARR Total Revenue 69% Rs. 3,261 Occupancy Rate RevPAR Renowned Five Star Hotel In the City of Solapur ARR : Average Room Revenue RevPAR: Revenue per Available Room 31

  33. Slide 33: Financial Performance

    Results Highlights About Us Hotel Division Financial Performance Moving towards Growth Prospects

  34. Slide 34: Consolidated Performance Highlights

    Consolidated Performance Highlights Revenue (Rs. Crs.) EBITDA (Rs. Crs.) PAT (Rs. Crs.) 2,338 2,371 637 624 418 406 1,671 1,318 379 353 244 232 941 186 97 2020 2021 2022 2023 2024 2020 2021 2022 2023 2024 2020 2021 2022 2023 2024 EBITDA Margin (%) PAT Margin (%) RoE (%) 28.8% 27.3% 18.5% 17.9% 31.8%

  35. Slide 35: Strong Core ROCE Profile

    Strong Core ROCE Profile Particulars (Rs. Crs.) FY23 FY24 ▪ For FY22, investments made to the tune of Rs. 145.54 crore for Unit Consolidated Debt 58 20 4’s DMC plant and Unit 3’s power plant is not considered, as the operations were work in progress. Consolidated Networth 1698 1893 Total Capital Emp

  36. Slide 36: Consistent Dividend Payout

    Consistent Dividend Payout 550% 500% 300% 200% 140% 160% FY19 FY20 FY21 FY22 FY23 FY24 Particulars (Rs. per share) FY19 FY20 FY21 FY22 FY23 FY24 Consolidated Book Value 183 206 281 406 524 584 Consolidated EPS 36 32 74 114 100 63 Dividend 2.80 3.20 4.00 6.00 10.00 11.00 35

  37. Slide 37: Moving towards Growth Prospects

    Results Highlights About Us Hotel Division Financial Performance Moving towards Growth Prospects

  38. Slide 38: Balaji Amines Ltd - Progressing steadily

    Balaji Amines Ltd - Progressing steadily Unit 4: Increased capacity Improvements at Greenfield Unit 4 : utilization & capacity Subsidiary Plant Capex Phase – 2 & 3 additions of Phase – 1 capex Expansion and commercialization of 90-acre project in MIDC Chincholi to Debottlenecking of the plant for Ca

  39. Slide 39: ESG & CSR Initiatives

    ESG & CSR Initiatives Distributed Sanitary Balak Palak Activity Napkin Incinerator Book Distribution and Vending Machine dt. 17.02.2024 at Saraswati High School, Tamalwadi and Z.P. School, Ghandora dt. 29.02.2024 Constructed SSC Board Exam classroom at Z. P. Books Primary School, Distribution for Go

  40. Slide 40: ESG & CSR Initiatives

    ESG & CSR Initiatives Constructed Toilet Contstruction of Block at Shree Toilet Block at Z.P. Basaveshwar School, Jalkot dt. Prashala, Kazikanbas 16.01.2024 dt 31.01.2024. Constructed kitchen shed at Constructed Muk Badhir classrooms at Niwasi Shala, Saraswati Mohol dt. Vidyalay, 03.01.2024 Tamalwad

  41. Slide 41: ESG & CSR Initiatives

    ESG & CSR Initiatives Contructed Boys Distibuted school and Ladies Hostels benches to Shakti at Government Primary Ashram Polytechnic College, School, Mulegaon, Nizambad dt. Solapur dt. 09.08.2023 25.08.2023 Donated 1000 trees for plantation under Maza Gav Maza Vatvruksh programme dt 14.06.2023 40

  42. Slide 42: Thank You

    For further information, please contact: Company : Balaji Amines Ltd. CIN - L24132MH1988PLC049387 Email - cs@balajiamines.com www.balajiamines.com Investor Relations Advisors : Orient Capital (a division of Link Group) Mr. Bhavya Shah +91 8082748577 bhavya.shah@linkintime.co.in Mr. Hitesh Agrawal +9

Balaji Amines — Q1 FY2025 Earnings Presentation on 6ix